Gregory Bradley v. HHS - Hepatitis B, Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (2019)
Case summary [AI summaries can sometimes make mistakes]
Gregory Bradley filed a petition on April 12, 2017, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he developed Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of a Hepatitis B vaccine received on March 24, 2015.
The respondent, the Secretary of Health and Human Services, maintained that the vaccine did not cause Mr. Bradley's conditions.
Settlement negotiations began in September 2018. The parties ultimately filed a stipulation on June 13, 2019.
Special Master Brian H. Corcoran reviewed the stipulation and found it to be reasonable, adopting it as the decision.
The stipulation awarded Mr. Bradley a lump sum of $65,000.00, payable to him, as compensation for all damages.
The decision was finalized on July 16, 2019. Joseph A.
Vuckovich represented the petitioner, and Jennifer L. Reynaud represented the respondent.
The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses.
Theory of causation
Petitioner Gregory Bradley alleged that a Hepatitis B vaccine administered on March 24, 2015, caused Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP). The respondent denied causation. The parties reached a settlement via stipulation, filed June 13, 2019. Special Master Brian H. Corcoran approved the stipulation on July 16, 2019, awarding a lump sum of $65,000.00 to Petitioner. The specific theory of causation, medical experts, and detailed evidence supporting or refuting the claim are not described in the public decision, which was resolved by stipulation. Petitioner was represented by Joseph A. Vuckovich, and Respondent by Jennifer L. Reynaud.
Source PDFs
USCOURTS-cofc-1_17-vv-00515